Delivery Order SPE2DB22D3016-SPE2DB25FALD6

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Armour Thyroid 90 mg tablets. The $17,270.97 firm-fixed-price contract has a performance period ending on September 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to procure a comprehensive range of pharmaceutical and medical...
This federal contract award, valued at $1,110.30, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Armour Thyroid 30 mg tablets in 100-count packages. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 28, 2022. The contract was not designated under any set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $6,226.43 contract is for the delivery of Armour Thyroid 90 mg tablets to support military treatment programs and facilities. This contract is not set-aside and is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a $1,622.86 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Armour Thyroid 60 mg tablets in 100-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen for providing a comprehensive range of pharmaceutical and medical supplies to support military...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Armour Thyroid 60 mg tablets. The $3,678.29 firm fixed-price delivery order contract has a completion date of January 23, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,750.94 firm fixed-price delivery order is for the supply of Armour Thyroid 90 mg tablets. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical sourcing and distribution company AmerisourceBergen Corporation. The contract, valued at $3,230.94, is for the provision of Armour Thyroid 60 mg tablets to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
This federal contract award, valued at $1,165.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Armour Thyroid 60 mg tablets in quantities of 100 and has a completion date of May 7, 2024. This is a firm fixed-price delivery order contract without any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. As a...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Armour Thyroid 60 mg tablets. The contract has a potential value of $2,135.65 and a completion date of March 8, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp serves as a prime contractor to DLA, providing a wide range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Armour Thyroid 60 mg tablets. The contract, valued at $3,651.85, was awarded on May 29, 2024 by the Medical Supply Chain division of the Defense Logistics Agency (DLA) and has an ultimate completion date of May 30, 2024. This is a Firm Fixed Price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FALD6
    Delivery Order

The federal government awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Armour Thyroid 60 mg tablets. The $1,604.96 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of January 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen, a for-profit organization, maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/25/25, 10:17 AM